COMMUNIQUÉS West-GlobeNewswire

-
Akari Therapeutics Announces Expanded Ophthalmology Program Based on Positive Emerging Data on LTB4-C5 Dual Action in Surface and Back of the Eye Diseases
26/04/2019 -
Oncology Venture Investor Events in Q2 2019 – new event
26/04/2019 -
ReWalk Robotics Regains Compliance with Nasdaq Listing Rules 5550(a) and 5550(b)
26/04/2019 -
Oncology Venture Investor Events in Q2 2019
26/04/2019 -
Forty Seven Inc. Expands Collaboration with Genentech to Include Third Clinical Trial in Non-Hodgkin’s Lymphoma
26/04/2019 -
Outlook Therapeutics Announces Addition of Jennifer M. Kissner, Ph.D. as Senior Vice President, Clinical Development
26/04/2019 -
Tauriga Sciences Inc. Creates Alternative Version of its Graphic Design for Mint Flavor Tauri-Gum Blister Pack
26/04/2019 -
Establishment Labs to Present at UBS Global Healthcare Conference
26/04/2019 -
Mereo Biopharma to Announce Preliminary Results for the Full Year 2018 and Host Conference Call on April 29, 2019
26/04/2019 -
Repligen Corporation Announces Agreement to Acquire Process Analytics Innovator C Technologies and Reports Preliminary First Quarter 2019 Financial Results
26/04/2019 -
Editorial in Pharmagenomics explains how DRP® can guide the treatment for breast cancer
26/04/2019 -
CURE Pharmaceutical Named “Innovative Business of the Year” By Oxnard Chamber of Commerce
26/04/2019 -
Inivata publishes positive clinical validation results and real-world utility for its InVisionFirst®-Lung liquid biopsy test
26/04/2019 -
miRagen Announces New Clinical Data for Cobomarsen in ATLL Patients at the 19th Annual HTLV Congress in Lima, Peru
26/04/2019 -
111 to Announce First Quarter 2019 Unaudited Financial Results on May 16, 2019
26/04/2019 -
Annual Report 2018 Active Biotech AB (publ)
26/04/2019 -
Novo Nordisk files for EU regulatory approval of oral semaglutide for the treatment of type 2 diabetes
26/04/2019 -
Vistin Pharma ASA: Annual Report 2018
26/04/2019 -
C-RAD and OPASCA announce strategic partnership
26/04/2019
Pages